This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, F.
Right arrow Articles by Tang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, F.
Right arrow Articles by Tang, H.

 Previous Article  |  Next Article 

Journal of Virology, June 2008, p. 5269-5278, Vol. 82, No. 11
0022-538X/08/$08.00+0     doi:10.1128/JVI.02614-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro{triangledown}

Feng Yang, Jason M. Robotham, Heather B. Nelson, Andre Irsigler, Rachael Kenworthy, and Hengli Tang*

Department of Biological Science, Florida State University, Tallahassee, Florida 32306-4370

Received 7 December 2007/ Accepted 20 March 2008

Cyclosporine (CsA) and its derivatives potently suppress hepatitis C virus (HCV) replication. Recently, CsA-resistant HCV replicons have been identified in vitro. We examined the dependence of the wild-type and CsA-resistant replicons on various cyclophilins for replication. A strong correlation between CsA resistance and reduced dependency on cyclophilin A (CyPA) for replication was identified. Silencing of CyPB or CyPC expression had no significant effect on replication, whereas various forms of small interfering RNA (siRNA) directed at CyPA inhibited HCV replication of wild-type but not CsA-resistant replicons. The efficiency of a particular siRNA in suppressing CyPA expression was correlated with its potency in inhibiting HCV replication, and expression of an siRNA-resistant CyPA cDNA rescued replication. In addition, an anti-CyPA antibody blocked replication of the wild-type but not the resistant replicon in an in vitro replication assay. Depletion of CyPA alone in the CsA-resistant replicon cells eliminated CsA resistance, indicating that CyPA is the chief mediator of the observed CsA resistance. The dependency on CyPA for replication was observed for both genotype (GT) 1a and 1b replicons as well as a GT 2a infectious virus. An interaction between CyPA and HCV RNA as well as the viral polymerase that is sensitive to CsA treatment in wild-type but not in resistant replicons was detected. These findings reveal the molecular mechanism of CsA resistance and identify CyPA as a critical cellular cofactor for HCV replication and infection.

* Corresponding author. Mailing address: Bio Unit I, Chieftain Way, Department of Biological Science, Florida State University, Tallahassee, FL 32306-4370. Phone: (850) 645-2402. Fax: (850) 644-0481. E-mail: tang{at}bio.fsu.edu

{triangledown} Published ahead of print on 2 April 2008.

Journal of Virology, June 2008, p. 5269-5278, Vol. 82, No. 11
0022-538X/08/$08.00+0     doi:10.1128/JVI.02614-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hughes, M., Gretton, S., Shelton, H., Brown, D. D., McCormick, C. J., Angus, A. G. N., Patel, A. H., Griffin, S., Harris, M. (2009). A Conserved Proline between Domains II and III of Hepatitis C Virus NS5A Influences both RNA Replication and Virus Assembly. J. Virol. 83: 10788-10796 [Abstract] [Full Text]  
  • Kenworthy, R., Lambert, D., Yang, F., Wang, N., Chen, Z., Zhu, H., Zhu, F., Liu, C., Li, K., Tang, H. (2009). Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation. Nucleic Acids Res 37: 6587-6599 [Abstract] [Full Text]  
  • Li, Q., Brass, A. L., Ng, A., Hu, Z., Xavier, R. J., Liang, T. J., Elledge, S. J. (2009). A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl. Acad. Sci. USA 106: 16410-16415 [Abstract] [Full Text]  
  • Qing, M., Yang, F., Zhang, B., Zou, G., Robida, J. M., Yuan, Z., Tang, H., Shi, P.-Y. (2009). Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein. Antimicrob. Agents Chemother. 53: 3226-3235 [Abstract] [Full Text]  
  • Liu, Z., Yang, F., Robotham, J. M., Tang, H. (2009). Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex. J. Virol. 83: 6554-6565 [Abstract] [Full Text]  
  • Chatterji, U., Bobardt, M., Selvarajah, S., Yang, F., Tang, H., Sakamoto, N., Vuagniaux, G., Parkinson, T., Gallay, P. (2009). The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication. J. Biol. Chem. 284: 16998-17005 [Abstract] [Full Text]  
  • Hanoulle, X., Badillo, A., Wieruszeski, J.-M., Verdegem, D., Landrieu, I., Bartenschlager, R., Penin, F., Lippens, G. (2009). Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B. J. Biol. Chem. 284: 13589-13601 [Abstract] [Full Text]  
  • Peng, H., Vijayakumar, S., Schiene-Fischer, C., Li, H., Purkerson, J. M., Malesevic, M., Liebscher, J., Al-Awqati, Q., Schwartz, G. J. (2009). Secreted Cyclophilin A, a Peptidylprolyl cis-trans Isomerase, Mediates Matrix Assembly of Hensin, a Protein Implicated in Epithelial Differentiation. J. Biol. Chem. 284: 6465-6475 [Abstract] [Full Text]  
  • Coelmont, L., Kaptein, S., Paeshuyse, J., Vliegen, I., Dumont, J.-M., Vuagniaux, G., Neyts, J. (2009). Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors. Antimicrob. Agents Chemother. 53: 967-976 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»